| |
| |
|
| Insider
Information: |
Landry Robert E |
| Relationship: |
EVP Finance CFO |
| City: |
Tarrytown |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
23,693 |
|
|
Indirect Shares
|
270 |
|
|
| Direct
Value |
$23,222,931 |
|
|
|
Indirect Value
|
$264,643 |
|
|
| Total
Shares |
23,963 |
|
|
| Total
Value |
$23,487,574 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 16.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Regeneron Pharmaceuticals Inc |
REGN |
EVP Finance CFO |
2024-02-02 |
23,693 |
2024-02-02 |
270 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
158 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REGN |
Regeneron Pharmaceuticals... |
SVP Fin, Dep CFO |
• – – |
2013-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2015-04-08 |
4 |
OE |
$272.70 |
$2,727,000 |
D/D |
10,000 |
15,000 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2015-04-08 |
4 |
D |
$449.50 |
$3,551,500 |
D/D |
(7,901) |
7,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2015-08-05 |
4 |
OE |
$272.70 |
$1,090,800 |
D/D |
4,000 |
11,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2015-08-05 |
4 |
S |
$591.78 |
$2,371,350 |
D/D |
(4,000) |
7,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-07 |
4 |
D |
$466.98 |
$688,329 |
D/D |
(1,474) |
7,625 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-07 |
4 |
OE |
$272.70 |
$545,400 |
D/D |
2,000 |
9,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-08 |
4 |
AS |
$469.91 |
$248,372 |
D/D |
(526) |
7,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-22 |
4 |
OE |
$272.70 |
$545,400 |
D/D |
2,000 |
9,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-22 |
4 |
D |
$476.10 |
$729,385 |
D/D |
(1,532) |
7,567 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-23 |
4 |
AS |
$474.14 |
$222,981 |
D/D |
(468) |
7,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-30 |
4 |
OE |
$272.70 |
$545,400 |
D/D |
2,000 |
9,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-30 |
4 |
D |
$486.91 |
$765,909 |
D/D |
(1,573) |
7,526 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-08-31 |
4 |
AS |
$487.88 |
$210,693 |
D/D |
(427) |
7,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-09-01 |
4 |
OE |
$272.70 |
$818,100 |
D/D |
3,000 |
10,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-09-01 |
4 |
D |
$501.29 |
$1,171,515 |
D/D |
(2,337) |
7,762 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-09-05 |
4 |
AS |
$500.33 |
$94,700 |
D/D |
(189) |
7,573 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2017-09-06 |
4 |
AS |
$496.51 |
$235,873 |
D/D |
(474) |
7,099 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2018-09-10 |
4 |
D |
$395.29 |
$889,798 |
D/D |
(2,251) |
4,848 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
SVP Finance & CFO |
• – – |
2018-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
12,500 |
17,348 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2019-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,625 |
24,973 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-12 |
4 |
OE |
$272.70 |
$136,350 |
D/D |
500 |
25,473 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-12 |
4 |
D |
$402.34 |
$158,120 |
D/D |
(393) |
25,080 |
0 |
- |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-13 |
4 |
AS |
$398.63 |
$42,806 |
D/D |
(107) |
24,973 |
0 |
% |
|
| REGN |
Regeneron Pharmaceuticals... |
EVP Finance CFO |
• – – |
2020-02-24 |
4 |
OE |
$272.70 |
$272,700 |
D/D |
1,000 |
25,973 |
0 |
- |
|
158 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
